While CML is defined by the presence of the BCR::ABL1 fusion gene, PMF typically involves mutations such as JAK2, representing two genetically distinct entities within the MPN spectrum. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.